ArticleInternal medicine (Tokyo, Japan)2025

Pemafibrate Reduced Liver Stiffness in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease Complicated with Hyperlipidemia and Liver Fibrosis with a Fibrosis-4 Index Above 1.3.

Tatsuki Ichikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.